tiprankstipranks
Trending News
More News >
OncoZenge AB (DE:8LY)
:8LY
Germany Market

OncoZenge AB (8LY) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
OncoZenge AB’s (8LY) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting OncoZenge AB is a Buy.
OncoZenge AB’s (8LY) 20-Day exponential moving average is 0.43, while OncoZenge AB’s (8LY) share price is €0.36, making it a Sell.
OncoZenge AB’s (8LY) 50-Day exponential moving average is 0.46, while OncoZenge AB’s (8LY) share price is €0.36, making it a Sell.

OncoZenge AB (8LY) Pivot Points

May 11, 2025, 12:32 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.40
0.40
0.40
0.40
0.40
0.40
0.40
Fibonacci
0.40
0.40
0.40
0.40
0.40
0.40
0.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoZenge AB (8LY) Moving Averages

May 11, 2025, 12:32 PM
Period
Simple
Exponential
MA5
0.40Sell
0.40Buy
MA10
0.41Sell
0.41Sell
MA20
0.43Sell
0.43Sell
MA50
0.50Sell
0.46Sell
MA100
0.45Sell
0.47Sell
MA200
0.50Sell
0.46Sell
OncoZenge AB’s (8LY) 10-Day exponential moving average is 0.41, while OncoZenge AB’s (8LY) share price is €0.36, making it a Sell.
OncoZenge AB’s (8LY) 100-Day exponential moving average is 0.47, while OncoZenge AB’s (8LY) share price is €0.36, making it a Sell.
OncoZenge AB’s (8LY) stock price is €0.36 and OncoZenge AB’s (8LY) 50-day simple moving average is 0.50, creating a Sell signal.
OncoZenge AB’s (8LY) stock price is €0.36 and OncoZenge AB’s (8LY) 100-day simple moving average is 0.45, creating a Sell signal.
OncoZenge AB’s (8LY) stock price is €0.36 and OncoZenge AB’s (8LY) 200-day simple moving average is 0.50, creating a Sell signal.

OncoZenge AB (8LY) Technical Indicators

May 11, 2025, 12:32 PM
Name
Value
Implied Action
RSI (14)
44.36
Neutral
STOCH (9,6)
27.86
Neutral
STOCHRSI (14)
13.68
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
10.26
Buy
Williams %R
-81.34
Buy
CCI (14)
-45.18
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
48.98
Neutral
ROC
5.26
Buy
OncoZenge AB’s (8LY) Relative Strength Index (RSI) is 44.36, creating a Neutral signal.
OncoZenge AB’s (8LY) Trend Strength Indicator (ADX) is 10.26, creating a Buy signal.
OncoZenge AB’s (8LY) Commodity Channel Index (CCI) is -45.18, creating a Neutral signal.
OncoZenge AB’s (8LY) Price Rate of Change (ROC) is 5.26, creating a Buy signal.

FAQ

Is 8LY a Buy, Hold, or Sell?
Based on 8LY’s technical indicators, 8LY is a Sell.
    What is 8LY’s RSI (14)?
    8LY’s RSI (14) is 44.36, which suggests 8LY is a Neutral.
      What is 8LY’s MACD?
      8LY’s MACD is -0.03, which suggests 8LY is a Buy.
        What is 8LY’s 5-day moving average?
        8LY’s 5-day moving average is 0.40, which suggests 8LY is a Sell.
          What is 8LY’s 20-day moving average?
          8LY 20-day moving average is 0.43, which suggests 8LY is a Sell.
            What is 8LY’s 50-day moving average?
            8LY’s 50-day moving average is 0.50, which suggests 8LY is a Sell.
              What is 8LY’s 200-day moving average?
              8LY’s 200-day moving average is 0.50, which suggests 8LY is a Sell.
                What is 8LY’s Williams % R (14)?
                8LY’s Williams % R (14) is -81.34, which suggests 8LY is a Buy.
                  What is 8LY’s CCI (14)?
                  8LY’s CCI (14) is -45.18, which suggests 8LY is a Neutral.
                    What is the share price of OncoZenge AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis